The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many Americans sadly do not realize the struggle of seeking answers during the cancer diagnostic journey until it’s too late.
The medical research community has been buried in data since well before the global COVID-19 pandemic. How they’re now managing the extreme additional influx of SARS-CoV-2 data determines the outcomes of a lab’s overall research capabilities.
As we continue to advance the analyses of SARS-CoV-2, our research experts have identified an important and novel mutational hotspot.
Newsletter updates for December 2020 – January 2021
